GeoVax Labs boosts ATM equity offering capacity from $4.5M to $30M

GeoVax Labs, Inc.

Maximum aggregate offering price under Sales Agreement with A.G.P./Alliance Global Partners increased from $4,486,846 to $30,000,000.
Sales Agreement originally dated September 25, 2024; amendment filed October 15, 2024.
Increase allows up to $30M in common stock sales via at-the-market offering.
Legal opinion on share legality filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.